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Abstract. 
 
The survival of motor neurons (
 
SMN
 
) gene is 
the disease gene of spinal muscular atrophy (SMA), a 
common motor neuron degenerative disease. The SMN 
protein is part of a complex containing several proteins, 
of which one, SIP1 (SMN interacting protein 1), has 
been characterized so far. The SMN complex is found in 
both the cytoplasm and in the nucleus, where it is con-
centrated in bodies called gems. In the cytoplasm, SMN 
and SIP1 interact with the Sm core proteins of spliceo-
somal small nuclear ribonucleoproteins (snRNPs), and 
they play a critical role in snRNP assembly. In the nu-
cleus, SMN is required for pre-mRNA splicing, likely 
by serving in the regeneration of snRNPs. Here, we re-
port the identiﬁcation of another component of the 
SMN complex, a novel DEAD box putative RNA heli-
case, named Gemin3. Gemin3 interacts directly with 
SMN, as well as with SmB, SmD2, and SmD3. Immu-
nolocalization studies using mAbs to Gemin3 show that 
it colocalizes with SMN in gems. Gemin3 binds SMN 
via its unique COOH-terminal domain, and SMN mu-
tations found in some SMA patients strongly reduce 
this interaction. The presence of a DEAD box motif in 
Gemin3 suggests that it may provide the catalytic activ-
ity that plays a critical role in the function of the SMN 
complex on RNPs.
Key words: helicase • nuclear bodies • DnRNP bio-
genesis • splicing • spinal muscular atrophy
 
S
 
PINAL
 
 muscular atrophy (SMA)
 
1
 
 is a common auto-
somal recessive disease that is the leading heredi-
tary cause of infant mortality. SMA is characterized
by degeneration of motor neurons of the anterior horn of
the spinal cord resulting in muscular weakness and atro-
phy (Roberts et al., 1970; Pearn, 1980; Czeizeil and Ham-
ula, 1989). SMA results from deletions or mutations in the
survival of motor neurons gene (
 
SMN
 
), which is dupli-
cated as an inverted repeat on human chromosome 5 at
5q13 (Brzustowicz et al., 1990; Melki et al., 1990, 1994;
Lefebvre et al., 1995; reviewed in Burghes, 1997). The telo-
meric copy of the 
 
SMN
 
 gene (
 
SMN1
 
) is deleted or mu-
tated in 
 
.
 
98% of SMA patients (Bussaglia et al., 1995;
Chang et al., 1995; Cobben et al., 1995; Hahnen et al.,
1995, 1996; Lefebvre et al., 1995; Rodrigues et al., 1995;
Velasco et al., 1996). The SMN protein is expressed in all
tissues of mammalian organisms, but particularly high lev-
els are expressed in motor neurons (Coovert et al., 1997;
Lefebvre et al., 1997). In contrast, individuals affected by
the most severe form of SMA, Werdnig-Hoffman syn-
drome or SMA type I, have barely detectable levels of
SMN in motor neurons (Coovert et al., 1997; Lefebvre et al.,
1997).
The 
 
SMN
 
 gene encodes a 294 amino acid protein that
does not have extensive sequence similarity to other
known proteins, however, it recently has been reported
that SMN contains a sequence similar to the ribonucle-
oprotein consensus sequence RNP1 (Bertrandy et al.,
1999). SMN is part of a multiprotein complex and one pro-
tein of the complex, SIP1 (SMN interacting protein 1), has
been characterized in detail so far (Liu et al., 1997). SMN
and SIP1 are found both in the nucleus and the cytoplasm
of somatic cells. In the nucleus, SMN and SIP1 are concen-
trated in bodies called gems, which are similar in size and
number to coiled bodies and are often associated with
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Abbreviations used in this paper:
 
 5
 
9
 
-RACE, rapid amplification of 5
 
9
 
-
cDNA ends; EST, expressed sequence tag; GST, glutathione S-trans-
ferase; MS, mass spectrometry; MS/MS, tandem mass spectrometry; nano-
ES, nanoelectrospray; ORF, open reading frame; SIP1, SMN interacting
protein 1; SMA, spinal muscular atrophy; SMN, survival of motor neu-
rons; snRNPs, small nuclear ribonucleoproteins. 
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them (Liu and Dreyfuss, 1996; Liu et al., 1997). In addition
to SMN and SIP1, the large cytoplasmic complex of which
they are part of also contains additional proteins, including
some of the Sm proteins that are common components of
spliceosomal small nuclear ribonucleoproteins (snRNPs;
Liu et al., 1997). The presence of the Sm proteins in the
SMN–SIP1 complex is a result of a direct interaction be-
tween SMN and several of the Sm proteins (Liu et al.,
1997; Pellizzoni et al., 1999). The role of the cytoplasmic
pool of the SMN–SIP1 complex has been studied by anti-
body microinjection experiments in 
 
Xenopus laevis 
 
oo-
cytes. These experiments revealed that SIP1 has a critical
role in the assembly of snRNPs, a process which takes
place in the cytoplasm where the Sm proteins combine
with snRNAs that were exported from the nucleus (Mattaj
and De Robertis, 1985; Mattaj, 1988; Luhrmann et al.,
1990; Fischer et al., 1997). Once properly assembled and
modified, the snRNPs recruit the necessary nuclear import
receptors and translocate into the nucleus where they
function in pre-mRNA splicing (Mattaj, 1986, 1988; Luhr-
mann et al., 1990; Neuman de Vegvar and Dahlberg, 1990;
Zieve and Sauterer, 1990). In contrast to the inhibitory ef-
fects of anti-SIP1 antibodies, the anti-SMN antibodies
show some stimulation of snRNP assembly (Liu et al.,
1997). By transfection of a dominant negative form of
SMN (SMN
 
D
 
N27) in HeLa cells, we found that SMN also
plays a critical role in the cytoplasmic assembly of snRNPs
(Pellizzoni et al., 1998). In the nucleus, the SMN
 
D
 
N27 pro-
tein causes a striking rearrangement of the snRNPs, colo-
calizing them with the mutant SMN
 
D
 
N27 in enlarged gems
(Pellizzoni et al., 1998). Using
 
 
 
in vitro experiments, we
have shown that SMN is required for pre-mRNA splicing,
likely for the regeneration or recycling of snRNPs (Pelliz-
zoni et al., 1998). SMN mutants found in SMA patients
lack this activity because they are defective in their inter-
action with the Sm proteins (Pellizzoni et al., 1999). Unlike
the several recycling factors described so far that are es-
sential for splicing, SMN and SIP1 do not contain DEAD/
DEAH motifs (reviewed in Staley and Guthrie, 1998).
Here, we report the molecular cloning and characteriza-
tion of a protein designated Gemin3 (for protein compo-
nent of gems number 3) that associates with SMN in vitro
and in vivo. Gemin3 is a novel DEAD box protein and is,
therefore, a putative RNA helicase. We have produced
mAbs to Gemin3 and show by immunofluorescence mi-
croscopy that it colocalizes with SMN in gems. Like SMN
and SIP1, Gemin3 can be isolated in a complex with sev-
eral spliceosomal snRNP proteins. We further found that
Gemin3 interacts directly with SMN and with several of
the spliceosomal snRNP core Sm proteins, including the B
and D2-3 proteins. The unique COOH-terminal domain of
Gemin3 mediates its interaction with SMN and its local-
ization to gems. The discovery of a DEAD box protein, a
likely RNA helicase, in the SMN complex is of particular
interest as the functions revealed so far suggest that this
complex has crucial activities in the biogenesis of RNPs.
To perform such functions, including assembly of the
snRNPs and the regeneration of active components of the
spliceosome, it would be expected that the SMN complex
can affect structural changes in its RNP targets. Of the
known components of the SMN complex, the DEAD box
protein Gemin3 is the most likely protein to have the ca-
pacity to perform such a function. Importantly, SMN pro-
teins with mutations found in SMA patients show a signifi-
cantly reduced interaction with Gemin3, suggesting that
the SMN complexes in these patients will be deficient in
this protein.
 
Materials and Methods
 
Identification of p105 Protein by Mass Spectrometry
 
The p105 protein was coimmunoprecipitated with anti-SMN mAb 2B1
and the band was excised from a single one-dimensional Coomassie
stained polyacrylamide gel and in-gel digested with trypsin (unmodified,
sequencing grade; Boehringer Mannheim Corp.) as described in
Shevchenko et al. (1996). Tryptic peptides were recovered from gel pieces
by extraction with 5% formic acid and acetonitrile. The combined extracts
were pooled together, dried in a speed vac, redissolved in 5% formic acid,
and analyzed by nanoelectrospray tandem mass spectrometry (nano-ES
MS/MS) as described in Wilm et al. (1996). Nano-ES MS/MS was per-
formed on a API III triple quadrupole instrument (PE Sciex) equipped
with a nano-ES ion source developed in EMBL (Wilm and Mann, 1996).
Comprehensive protein and expressed sequence tag (EST) databases
were searched using PeptideSearch v. 3.0 software developed by M. Mann
and P. Mortensen (University of Southern Denmark, Odense, Denmark).
No limitations on protein molecular weight and species of origin were im-
posed.
 
Cloning of the Gemin3 cDNA
 
Several peptides of the p105 band analyzed by MS identified a human
EST sequence (clone #AA303940) using the peptide sequence tag algo-
rithm. The EST clone was assumed to be incomplete since it lacked a start
codon and encoded for a putative protein of only 456 amino acids. The
cloning of the full-length Gemin3 cDNA was achieved by hybridization
screening of a human leukemia 5
 
9
 
-STRETCH PLUS cDNA library (from
CLONETECH) using a subfragment (EcoR1–EcoR1) of the EST clone
#AA303940 as a probe. The EST EcoR1 fragment contained a region of
the Gemin3 open reading frame (ORF) encoding amino acids 368–548. 12
independent partial cDNA clones with insert sizes ranging from 1–2.5 kb
were isolated, all of which contained overlapping regions of the same
ORF that encoded for a putative protein of 824 amino acids. Since the
clone lacked an in frame stop codon upstream of the start codon, we per-
formed two successive rounds of rapid amplification of 5
 
9
 
-cDNA ends by
PCR (5
 
9
 
-RACE PCR) to extend further upstream the cloning of the
Gemin3 cDNA.
 
 
 
In brief, total mRNA from HeLa-S3 cells was prepared
using the TRIZOL reagent (Life Technologies, Inc.). For the generation
of cDNA, 2 
 
m
 
g of mRNA was reverse-transcribed using Superscript™II
reverse transcriptase (Life Technologies, Inc.). The reaction was primed
with Gemin3 cDNA-specific primers, GSPA (5
 
9
 
-TTCCACTTCCAG-
GCCG) or GSPC (5
 
9
 
-TCTTGGGGCTTTCCTCAGG), in the first or sec-
ond round of RACE, respectively. The cDNAs were then purified using a
GlassMAX spin cartridge, tailed with dCTP and TdT, and amplified by
PCR using the Gemin3 specific primer GSP2 (5
 
9
 
-TCTTTCCTCTC-
CTCCC) and the Universal Amplification primer (UAP) from Life
Technologies, Inc. (5
 
9
 
-CUACUACUACUAGGCCACGCTTCGACT-
AGTAGTAC). PCR products were cloned into the pCR2.1 vector by TA
cloning (Invitrogen) and sequenced. The two independent 5
 
9
 
-RACE ex-
periments yielded products terminating at the same 5
 
9
 
 position. The ex-
tended 5
 
9
 
 Gemin3 cDNA contained an in frame stop codon upstream of
the start codon. By in vitro transcription–translation, we confirmed that
the cloned cDNA encoded the full-length Gemin3 protein (see below).
 
Production of Proteins In Vitro
 
The [
 
35
 
S]methionine-labeled proteins were produced by an in vitro cou-
pled transcription–translation reaction (Promega Biotech) in the presence
of [
 
35
 
S]methionine (Nycomed Amersham, Inc.). 6His-Gemin3 and 6His-
SMN fusion protein was expressed from a pET bacterial expression sys-
tem in the 
 
Escherichia coli
 
 strain BL21(DE3) and purified using nickel
chelation chromatography using Novagen His-bind buffer. GST–Gemin3
fusion protein was expressed from a GST expression vector pGEX-5X-3
(Pharmacia Biotech, Inc.) in the 
 
E. coli
 
 strain BL21 and purified using glu-
tathione-Sepharose (Pharmacia Biotech, Inc.) according the manufac-
turer’s protocol. 
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Production of mAbs to Gemin3
 
Anti-Gemin3 antibodies 11G9 and 12H12 were prepared by immunizing
Balb/C mice with 6His-tag COOH-terminal domain of Gemin3 (from
amino acids 368–548) purified from nickel chelation chromatography us-
ing Novagen His-Bind buffer kit. Hybridoma production, screening, and
ascites fluid production were performed as previously described (Choi
and Dreyfuss, 1984).
 
Immunoprecipitation and Immunoblotting
 
Immunoprecipitations of in vitro
 
 
 
translated proteins were carried out in
the presence of 1% Empigen BB buffer as previously described (Choi and
Dreyfuss, 1984). Immunoprecipitations of SMN, the Sm proteins, and
Gemin3 from cells were carried out using total HeLa lysate in the pres-
ence of 1% Empigen BB buffer as previously described (Choi and Drey-
fuss, 1984). Immunoprecipitations and purifications of the SMN, Gemin2,
Sm, and Gemin3 complexes were carried out using total HeLa lysate in
the presence of 0.5% Triton X-100 as previously described (Pinol-Roma
et al., 1988). For immunoblotting, proteins were resolved on 12.5% SDS-
polyacrylamide gels and transferred to a nitrocellulose membrane
(Schleicher and Schuell, Inc.) using a BioTrans Model B Transblot appa-
ratus (Gelman Science) according to the manufacturer’s instructions. The
membranes were then incubated in blocking solution (PBS 5% nonfat
milk) for at least 1 h at room temperature, rinsed with cold PBS, and then
incubated in blocking solution with primary antibody for at least 1 h at
room temperature. The membranes were subsequently washed three
times in PBS containing 0.05% NP-40, and bound antibodies were de-
tected using the peroxidase-conjugated goat anti–mouse IgG plus IgM
(Jackson ImmunoResearch Laboratories). The antibody-decorated pro-
tein bands were visualized by an ECL Western blotting kit (Nycomed
Amersham, Inc.) after washing three additional times with PBS contain-
ing 0.05% NP-40.
 
Cell Culture and Treatments
 
HeLa cells were cultured in DME supplemented with 10% FBS (both
from GIBCO BRL). HeLa cells, plated on glass coverslips, were trans-
fected by the standard calcium phosphate method. Following overnight in-
cubation with DNA, cells were washed and fresh medium was added.
Transfected cells were fixed and processed by immunofluorescence stain-
ing after an additional 24–36 h of incubation.
 
Immunofluorescence Microscopy
 
Immunofluorescence staining was carried out essentially as previously de-
scribed (Choi and Dreyfuss, 1984). Double-label immunofluorescence ex-
periments were performed by separate sequential incubations of each pri-
mary antibody diluted in PBS containing 3% BSA, followed by the
specific secondary antibody coupled to either FITC or Texas red. All incu-
bations were carried out at room temperature for 1 h. Laser confocal fluo-
rescence microscopy was performed with a Leica
 
 
 
TCS 4D confocal micro-
scope. Images from each channel were recorded separately and, where
indicated, the files were merged. Antibodies used in these experiments
were as follows: mouse IgG1 monoclonal anti-Gemin3 (11G9 and 12H12;
this work); mouse IgG1 monoclonal anti-SMN (2B1; Liu and Dreyfuss,
1996); rabbit polyserum anti-p80 coilin (R288; Andrade et al., 1991);
mouse IgG3 monoclonal anti-Sm (Y12; Lerner et al., 1981); and SP2/O, a
nonimmunoglobulin chains secreting mouse hybridoma (ATTC). The
rabbit affinity-purified anti-Exon7 antibody was made against the poly-
petide encoded by the SMN exon7 (Liu
 
 
 
et al., 1997).
 
In Vitro Protein-binding Assay
 
Purified GST or GST fusion proteins (2 
 
m
 
g) bound to 25 
 
m
 
l of glutathione-
Sepharose beads were incubated with 10
 
6
 
 cpm of the in vitro translated
protein mix in 1 ml of binding buffer (50 mM Tris-HCl, pH 7.5, 200 mM
NaCl, 2 mM EDTA, 0.1% NP-40, 2 
 
m
 
g/ml leupeptin and pepstatin A, and
0.5% aprotinin). After incubation for 1 h at 4
 
8
 
C, the resin was washed five
times with 1 ml of binding buffer. The bound fraction was eluted by boil-
ing in SDS-PAGE sample buffer, and run on SDS-PAGE. The gels were
fixed for 30 min and the signal enhanced by treatment with Amplify solu-
tion (Nycomed Amersham, Inc.). For direct
 
 
 
in vitro binding (see Fig. 7 C),
purified GST or GST–Gemin3 proteins (2 
 
m
 
g) bound to 25 
 
m
 
l of glu-
tathione-Sepharose beads were incubated with 5 
 
m
 
g of purified 6His-SMN
 
or 6His-mB in 1 ml of binding buffer (50 mM Tris-HCl, pH7.5, 100 mM
NaCl, 2 mM EDTA, 0.05% NP-40, 2 
 
m
 
g/ml leupeptin and pepstatin A,
and 0.5% aprotinin). After incubation for 1 h at 4
 
8
 
C, the resin was washed
five times with 1 ml of binding buffer. The bound fraction was eluted by
boiling in SDS-PAGE sample buffer, and analyzed by SDS-PAGE and
Western blot using a rabbit polyclonal anti-His-tag antibody (Santa Cruz
Biotech).
 
Cell Fractionation and Chromatography
 
HeLa cells were fractionated according to Dignam et al. (1983). S100 frac-
tions (400 
 
m
 
l of 
 
z
 
20 mg/ml protein) in buffer F (20 mM Tris-HCl, pH 7.4,
0.1 mM EDTA, 1 mM DTT, 10% glycerol, 500 mM KCl) were loaded on a
Superose 6 HR 10/30 column (Pharmacia Biotech, Inc.). The column was
then washed with buffer A (20 mM Tris-HCl, pH 7.4, 200 mM NaCl, 2.5%
glycerol). Fractions (0.5 ml) were collected, and 30 
 
m
 
l of each fraction was
resolved on SDS-PAGE, followed by Western blotting.
 
Accession Number
 
The Gemin3 GenBank/EMBL/DDBJ accession number is AF171063.
 
Results
 
Gemin3, a Novel SMN-Interacting Protein with a 
DEAD Box RNA Helicase Domain
 
Immunoprecipitations from [
 
35
 
S]methionine-labeled HeLa
cell lysates with anti-SMN and anti-SIP1 mAbs revealed
the presence of several protein components in the SMN–
SIP1 complex (Liu et al., 1997). Among the proteins that
Figure 1. Immunoprecipitation of the SMN complex with an
mAb against SMN. A, Immunoprecipitations using anti-SMN
mAb 2B1 and [35S]methionine-labeled HeLa cell. The immuno-
precipitated proteins were analyzed by SDS-PAGE and autora-
diography (24-h exposure). Antibody 2B1 immunoprecipitates
SMN, Gemin2, Sm proteins B, B9, D1-3, E, F, and G, and a group
of proteins indicated as p175, p105, p97, p95, p60, and p50. The
SP2/O lane shows the background of immunoprecipitation. B, A
longer exposure (36 h) of the bottom part of the gel to visualize
the Sm proteins more clearly. The positions of the molecular
weight markers are indicated on the left (in kD). 
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can be coimmunopurified with anti-SMN and anti-SIP1
antibodies, only some of the major low molecular mass
proteins, identified as the Sm proteins, have been charac-
terized so far (Liu et al., 1997; Fig. 1, A and B). In addition
to SMN, SIP1, and the Sm proteins, there is a doublet at
 
z
 
97 kD, and additional bands at 175, 95, 60, and 50 kD
that coimmunopurified with the anti-SMN antibody. The
two proteins of the 97-kD doublet were eluted from the
gel, digested with trypsin, and the resulting peptides se-
quenced by nano-ES MS as described previously (Shev-
chenko et al., 1996; Wilm et al., 1996; Fig. 2). In this paper,
we describe the molecular cloning and characterization of
the high molecular weight protein of this doublet (p105).
Several peptides from this band identified a human EST
sequence (clone #AA303940) using the peptide sequence
tag algorithm (Fig. 2). Several additional cDNA clones
were obtained by hybridization screening of a human leu-
kemia 5
 
9
 
-STRETCH PLUS cDNA library, using this EST
clone as a probe. We isolated 12 independent partial
cDNA clones with insert sizes ranging from 1–2.5 kb, all of
which contained overlapping regions of the same ORF. 5
 
9
 
RACE PCR was used to extend this cDNA further up-
stream. A cDNA clone containing the longest ORF was
constructed and conceptual translation of its nucleotide
sequence revealed a potential initiator methionine, pre-
ceded by an in frame stop codon. This cDNA encodes a
putative protein of 824 amino acids with a calculated mo-
lecular mass of 92.2 kD and a pI of 6.5. We then deter-
mined that this cDNA encodes the p105 protein that co-
immunoprecipitates with SMN (see Gemin3 and SMN
Colocalize in Gems). Thus, this is a full-length cDNA
clone for a novel component of the SMN complex that we
termed Gemin3, for component of gems number 3 (see be-
low). Because of the existence of several unrelated pro-
teins called SIP1 (Mylin
 
 
 
et al., 1994; Zhang and Wu, 1998;
Verschueren et al., 1999), we tentatively rename the SMN-
interacting SIP1 (Liu et al., 1997) Gemin2, for component
of gems number 2 (SMN is the first component of gems
identified; Liu and Dreyfuss, 1996). Gemin3 has high
amino acid sequence similarities with the RNA helicase
Figure 2. Sequencing of
Gemin3 by nano-ES MS/MS.
A, Part of the spectrum of
the unseparated in-gel tryptic
digest of p105 band. Peptide
ions, designated by T, are au-
tolysis products of trypsin
and were identified by com-
parison with the spectrum ac-
quired from the control sam-
ple. Other peptide ions
observed in the spectrum
were in turn isolated by the
first mass analyzer of a triple
quadrupole instrument, frag-
mented in the collision cell,
and their tandem mass spec-
tra acquired. Upon searching
a comprehensive protein se-
quence database using tan-
dem mass spectrometric data
(see below) peptide ions
designated with filled trian-
gles were identified as tryptic
peptides originating from
PTB-associated splicing fac-
tor (P23246). The presence
of PTB-associated splicing
factor in the SMN complex turned out to be negative by both coimmunoprecipitation and direct binding to several components of the
SMN complex (data not shown). Peptide ions designated with asterisks were identified as peptides from immunoglobulins used for im-
munoaffinity purification. Tandem mass spectra acquired from the peptide ions having m/z 552.9 and 622.5 did not identify any protein
in a protein sequence database. However when the search was performed against a comprehensive database of expressed sequence tags
(dbEST), the peptide sequence VLISTDLTSR from EST clone W65908 was identified as matching the tandem mass spectrum. After
full-length sequence had been obtained (see Materials and Methods) the tandem mass spectrum acquired from the peptide ion at m/z
622.5 was matched to the peptide LNSSDPSLIGLK present in the sequence of Gemin3. B, Tandem mass spectrum, acquired from dou-
bly charged peptide precursor ion having m/z 552.9. Continuous series of the fragment ions containing the COOH terminus of the pep-
tide (Y99-ions; Roepstorff and Fohlman, 1984) is produced upon collisional fragmentation of tryptic peptides. A short stretch of the pep-
tide sequence was deduced unambiguously by considering precise mass differences between adjacent Y99-ions (in bold) observed in a
part of the spectrum above m/z of the parent ion. Note that Leu and Ile residues have the same nominal mass and, therefore, are usually
not distinguished by MS. The determined piece of a peptide sequence was combined with the masses of correspondent Y99-ions and
with the mass of intact peptide into a peptide sequence tag (Mann and Wilm, 1994) that was subsequently used for searching protein
and EST databases by the program PeptideSearch. Once the database search produced a hit, the correspondent peptide sequence was
retrieved from a database and masses of the ions from the NH2-terminal fragment series (A- and B-ions) were used to verify the match.
This enabled highly confident protein identification albeit a single peptide containing only ten amino acid residues was matched to the
sequence of EST clone. 
Charroux et al. 
 
A DEAD Box Protein in the SMN Complex
 
1185
 
core region of the human eukaryotic initiation factor 4A-
II (eIF4A-II). eIF4A-II is a DEAD box RNA helicase
that belongs to the SFII superfamily of helicase (reviewed
in De la Cruz et al., 1999). A scheme depicting the modu-
lar structure of Gemin3 and the predicted amino acid se-
quence of Gemin3 aligned with the sequence of eIF4A-II
are presented in Fig. 3. This alignment showed the pres-
ence of seven motifs in the Gemin3 protein, which are
characteristic of the RNA helicase core region. Database
searches with the COOH-terminal nonconserved region
did not reveal significant homology to any other protein or
any recognizable motifs.
 
Production of mAbs to Gemin3
 
To investigate the interaction of Gemin3 with SMN and to
characterize Gemin3 further, we generated mAbs to it by
immunizing mice with a purified bacterially produced re-
combinant 6His-Gemin3 fragment (amino acids 368–548).
Two hybridomas, 11G9 and 12H12, were selected for addi-
tional studies. Several lines of evidence demonstrate that
these hybridomas indeed produce mAbs that recognize
Gemin3 specifically. First, both 11G9 and 12H12 specifi-
cally immunoprecipitate Gemin3 produced by in vitro
transcription and translation from the Gemin3 cDNA, but
do not immunoprecipitate similarly produced hnRNP A1
or SMN proteins (Fig. 4 A). Second, the mAb 11G9 ef-
ficiently recognized purified 6His-Gemin3 on Western
blots, but did not recognize similarly produced and puri-
fied 6His-Gemin2 (Fig. 4 B). Finally, on an immunoblot of
total HeLa lysate, both 11G9 and 12H12 recognized a sin-
gle protein of 
 
z
 
105 kD (Fig. 4 C). mAbs 11G9 or 12H12
did not recognized a specific protein on a Western blot
with total mouse 3T3 cell lysate or 
 
Xenopus
 
 
 
laevis
 
 XL-177
cell lysate. However, 11G9 specifically immunoprecipi-
tated a single protein of 
 
z
 
105 kD from these cell lysates
(data not shown), suggesting that Gemin3, like SMN, is
conserved in vertebrates.
 
Gemin3 and SMN Colocalize in Gems
 
Indirect laser confocal immunofluorescence microscopy
using antibodies 11G9 and 12H12 was performed on HeLa
cells to determine the subcellular localization of Gemin3.
Fig. 5 A shows that Gemin3 is found throughout the cyto-
plasm and also displays intense staining of prominent dis-
crete nuclear bodies that are readily discernible by differ-
ential interference contrast (DIC; Fig. 5 B). This pattern is
similar to that seen for SMN and Gemin2 (Liu and Drey-
fuss, 1996; Liu et al., 1997), except that the nucleoplasmic
staining of Gemin3 is stronger. To determine if the nuclear
structures stained by 11G9 are gems or coiled bodies, we
Figure 3. Gemin3 encodes a
DEAD box containing RNA
helicase. A, Schematic repre-
sentation of the modular
structure of Gemin3. The
seven helicase motifs (I, Ia,
II, III, IV, V, and VI) are
represented by boxes with
conserved amino acids in
white. Upper cases are for
the highly conserved resi-
dues, lower cases for the less
conserved ones. The heli-
case motifs (reviewed in De
la Cruz et al., 1999) are
boxed in black. The SMN in-
teracting domain (amino ac-
ids 456–547) is boxed in gray.
B, Amino acid sequence
alignment of human Gemin3
and the human DEAD box
ATP-dependent RNA heli-
case eIF4A-II. The NH2-ter-
minal half of Gemin3 con-
tains a DEAD box RNA
helicase domain whereas the
COOH-terminal half does
not show homology to any
protein in the database.
Light gray indicates similar
amino acids, and dark gray
indicates identical amino ac-
ids. The position of the seven
helicase motifs, as well as the
SMN interacting domain, are
indicated. 
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performed double-label immunofluorescence experiments
using antibodies against Gemin3 and either p80 coilin as a
marker of coiled bodies (Andrade
 
 
 
et al., 1991) or SMN as
a marker of gems (Liu and Dreyfuss, 1996; Fig. 5). In many
cell lines, gems and coiled bodies entirely overlap by anti-
body staining, however, in the HeLa PV strain used here,
these two bodies are frequently found separate from each
other (Liu and Dreyfuss, 1996; Matera and Frey, 1998).
Therefore, we used HeLa PV cells to examine whether
Gemin3 is located in gems or in coiled bodies. As can be
seen in Fig. 5, C and D, the nuclear structures that con-
tain Gemin3 are clearly distinct from coiled bodies, but
Gemin3 completely colocalized with SMN in gems (Fig. 5
E). The colocalization of Gemin3 with SMN strongly sup-
ports the conclusion that these two proteins exist as a com-
plex in the cell. Gemin3 is thus the third constituent of
gems described so far. Compared with visual observation,
the confocal photographs in Fig. 5, slightly overestimates
the nuclear staining and underestimates the cytoplasmic
staining for Fig. 5, C and D.
 
Gemin3 Is in a Complex with SMN, Gemin2, and the 
Spliceosomal Sm Proteins
 
To characterize further the Gemin3 complex, immunopre-
cipitations using anti-Gemin3 mAbs and [
 
35
 
S]methionine-
labeled HeLa cells were carried out in the presence of
either Triton X-100 or the more stringent detergent, Em-
pigen BB (Matunis et al., 1994). The immunoprecipitated
proteins were then analyzed by SDS-PAGE. As refer-
ences for these immunoprecipitations, we also included an
immunoprecipitation with the anti-Sm mAb Y12 (Lerner
and Steitz, 1979; Lerner et al., 1981) and an immunopre-
cipitation with the anti-SMN mAb 2B1. As shown in Fig. 6
A, several proteins can be coimmunoprecipitated with
Gemin3 and the pattern of immunoprecipitated proteins is
very similar to that obtained with the anti-SMN antibody.
In addition to Gemin3, SMN, and Gemin2, there are sev-
eral prominent bands at 175, 95, and 50 kD. The two
groups of proteins at 28 and 15 kD have been identified
previously as the Sm B/B
 
9
 
, D1-3, E, F, and G proteins of
snRNPs (Liu et al., 1997). In addition, there are bands that
coimmunoprecipitate only with anti-SMN (at 60 kD) or
anti-Gemin3 (at 115 kD) mAbs. As further evidence for
the specificity of the antibodies used, the immunoprecipi-
tations were performed in the presence of Empigen BB.
Under these conditions, anti-Gemin3 and anti-SMN anti-
bodies immunoprecipitate Gemin3 and SMN proteins re-
spectively (Fig. 6, 
 
1
 
 Empigen BB, lane 11G9 and lane
2B1, respectively). Interestingly, a protein of 95 kD is still
present under these conditions in both of these immuno-
precipitations, but not in the control SP2/O immunopre-
cipitation, suggesting that this unidentified protein inter-
acts tightly with both Gemin3 and SMN.
To confirm the coimmunopurification results, we tested
for interaction of Gemin3 with SMN, Gemin2, and the Sm
proteins in HeLa cells in vivo by immunoprecipitations
and Western blot experiments. The anti-Gemin3 mAb
11G9 was used for immunoprecipitation from total HeLa
cell extracts, and these were then resolved by SDS-PAGE
and an immunoblot was probed with the anti-SMN anti-
body (Liu and Dreyfuss, 1996). As shown in Fig. 6 C (lane
11G9 IP), 2B1 readily detects SMN in the 11G9 immuno-
precipitates, indicating that SMN is coimmunoprecipitated
with Gemin3. Because SMN is associated with Gemin2 to
form a stable complex in vivo and in vitro (Liu et al.,
1997), we also investigated whether Gemin3 could be
coimmunoprecipitated with Gemin2. As shown in Fig. 6 C,
the anti-Gemin2 mAb 2S7 clearly detects Gemin2 in the
anti-Gemin3 11G9 immunoprecipitates (Fig. 6 C, lane
11G9 IP). In a reciprocal experiment, the Gemin3 protein
could also be coimmunoprecipitated by the anti-SMN
mAb 2B1 (Fig. 6 D, lane 2B1 IP) and the anti-Gemin2
mAb 2S7 (Fig. 6 D, lane 2S7 IP). Because SMN and
Gemin2 are found in a complex with the Sm proteins, we
asked whether Gemin3 can be coimmunoprecipitated with
the spliceosomal snRNP Sm core proteins as well. Fig. 6 D
shows that Gemin3 is present in the anti-Sm mAb Y12 im-
Figure 4. mAbs 11G9 and
12H12 are specific for
Gemin3. A, Myc-tagged
Gemin3, hnRNP A1, and
SMN proteins were produced
in rabbit reticulocyte lysate in
the presence of [35S]methio-
nine. The labeled proteins
were immunoprecipitated us-
ing mAb 11G9 and 12H12,
and the immunoprecipitated
material analyzed by SDS-
PAGE and autoradiography.
10% of the in vitro translated
protein is shown on the left
panel. B, Immunoblotting us-
ing mAb 11G9 on purified
6His-Gemin2 and 6His-
Gemin3. C, Immunoblotting
using mAbs 12H12 and 11G9
on total HeLa extract. Note that, in addition to the strong p105 signal, 12H12, but not 11G9, weakly detects a protein of z55 kD. The
position of the molecular weight markers is indicated on the left (in kD). 
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munoprecipitates (Fig. 6 D, lane IP Y12) like SMN and
Gemin2 (Liu et al., 1997). No Gemin3, SMN, Gemin2, or
Sm proteins were detected in a SP2/O immunoprecipitate
(data not shown). These results demonstrate that Gem-
in3, SMN, Gemin2, and the Sm proteins are associated in
vivo in a complex that can be immunoprecipitated by ei-
ther anti-SMN, anti-Gemin2, anti-Sm, or anti-Gemin3 an-
tibodies.
Further support for the existence in vivo of a complex
that contains SMN, Gemin2, and Gemin3 was obtained from
gel filtration experiments. HeLa cytoplasmic S100 extract
was fractionated on a Superose 6 HR 10/30 high perfor-
mance gel filtration column and each fraction was sub-
jected to SDS-PAGE, followed by Western blot with anti-
Gemin3, anti-SMN, and anti-Gemin2 mAbs. Gemin3, SMN,
and Gemin2 comigrated and showed a peak at 
 
z
 
800 kD,
Figure 5. The Gemin3 pro-
tein colocalizes with SMN in
gems. A, Laser confocal im-
age of indirect immunofluo-
rescence on HeLa cells using
mAb 12H12 against the
Gemin3 protein. Note the
general cytoplasmic staining,
as well as nucleoplasmic and
discrete nuclear structures.
B, DIC image of the same
cell shown in A, arrows in-
dicate gems. C and D, Su-
perimposed laser confocal
images of double-label im-
munofluorescence micros-
copy experiments using anti-
bodies against coiled bodies
marker, p80 coilin (C and D,
green), anti-Gemin3 11G9
(C, red), and anti-SMN anti-
body 2B1 (D, red). E, Super-
imposed laser confocal
images of double-label im-
munofluorescence micros-
copy experiments using mAb
against Gemin3 (red) and a
rabbit affinity-purified anti-
body against exon7 of the hu-
man SMN protein (green).
Colocalization of green and
red results in yellow color.
Dashed lines demarcate the
nucleus. 
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Figure 6. Gemin3 is in a
complex with SMN, Gemin2,
and the spliceosomal Sm pro-
teins. A and B, Immunopre-
cipitations of [35S]methio-
nine-labeled HeLa cell using
mAbs specific to SMN (2B1),
Gemin3 (11G9), and the
snRNP core Sm proteins
(Y12). The immunoprecipi-
tated proteins were analyzed
by SDS-PAGE and autora-
diography (24-h exposure).
The immunoprecipitations
were performed in the pres-
ence of Empigen BB or Tri-
ton X-100 as indicated. The
several proteins immunopre-
cipitated are indicated on the
right. B, A longer exposure
(36 h) of the bottom part of
the immunoprecipitation in
the presence of Triton X-100
to visualize the Sm proteins
more clearly. C and D,
Gemin3, SMN, Gemin2, and
the Sm proteins can be coim-
munoprecipitated in vivo. C,
mAbs against Gemin3 coim-
munoprecipitate SMN and
Gemin2. Immunoprecipita-
tion from total HeLa extract
was done with mAb 11G9
and the immunoprecipitated
proteins were analyzed by
Western blot using 2B1 (anti-
SMN) or 2S7 (anti-Gemin2)
antibodies. D, mAbs against
SMN, Gemin2 and the Sm
proteins coimmunoprecipi-
tate Gemin3. Immunoprecip-
itation from total HeLa ex-
tract was done with mAbs
against SMN (lane 2B1 IP),
Gemin2 (lane 2S7 IP), or the
Sm proteins (lane Y12 IP).
The immunoprecipitated
proteins were analyzed by
Western blot using the anti-
Gemin3 mAb 12H12. The
positions of the molecular
weight markers are indi-
cated on the left (in kD). The
positions of the light chain
(l.c) and heavy chain (h.c) of
the antibodies used for im-
munoprecipitation are indi-
cated. E, Gemin3, SMN, and
Gemin2 are found in a com-
plex of 800 kD or more in the
cytoplasm. HeLa cytoplas-
mic S100 extract was frac-
tionated on a Superose 6 HR
10/30 column. The fractions were analyzed by SDS-PAGE, and the Gemin3, SMN, and Gemin2 proteins were detected by Western
blot. The fraction number and the molecular weight standards are indicated. 
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demonstrating that they are components of a large mac-
romolecular complex (Fig. 6 E). Interestingly, a second
pool of SMN-Gemin2, lacking Gemin3, is observed in a
lower molecular weight complex that peaks at 
 
z
 
150 kD,
suggesting that at least two different SMN–Gemin2 sub-
complexes exist in vivo. However, we cannot exclude the
possibility that the 150-kD subcomplex corresponds to a
fraction of SMN-Gemin2 that dissociates from Gemin3
during cell fractionation and/or chromatography. We re-
ported previously that a SMN–Gemin2 complex mi-
grates at 
 
.
 
300 kD after filtration of a cytoplasmic S100
extract on a TSK-GEL G3000-SW column (Liu et al.,
1997). The Superose 6 HR 10/30 gel filtration column
used here allowed us to obtain a better resolution of the
cytoplasmic SMN complex and to better estimate its size
as 
 
z
 
800 kD.
Figure 7. A–C, Gemin3 interacts directly with SMN and several Sm pro-
teins in vitro. A, SMN interacts with GST-Gemin3 in vitro. In vitro trans-
lated [35S]methionine-labeled myc-SMN and myc-Gemin2 proteins were
incubated with purified GST-Gemin3 as described in Materials and Meth-
ods. Bound proteins were analyzed by SDS-PAGE and fluorography. The
in vitro translation panel shows 2% of the input. B, Gemin3 interacts with a
subset of the Sm proteins in vitro. In vitro translated [35S]methionine-
labeled myc-Sm proteins B, D1, D2, D3, E, F, and G were incubated with
purified GST-Gemin3 or GST-SMN as described in Materials and Methods.
Bound proteins were analyzed by SDS-PAGE and fluorography. The in
vitro translation panel shows 2% of the input. C, Gemin3 interacts directly
with SMN and SmB in vitro. Wild-type recombinant 6His-SMN or 6His-
SmB proteins were incubated with purified GST-Gemin3, or GST alone.
Input lane shows 10% of 6His-SMN and 6His-SmB. Bound proteins were
analyzed by SDS-PAGE and Western blot. D, Mutations found in SMA se-
verely affect SMN interaction with Gemin3. In vitro translated [35S]me-
thionine-labeled wild-type myc-SMN and the indicated mutant proteins
were incubated with purified GST-Gemin3 as described in Materials and
Methods. Bound proteins were analyzed by SDS-PAGE and fluorography.
The in vitro translation panel shows 2% of the input. E, SMN oligomeriza-
tion does not affect the Gemin3 interaction. In vitro translated [35S]me-
thionine-labeled myc-Gemin3 or myc-SmB proteins were incubated with
purified GST or GST-SMN that had been preincubated or not with 6His-
SMN wild-type protein as described in Materials and Methods. Bound
myc-Gemin3 and myc-SmB proteins were analyzed by SDS-PAGE and
fluorography (top). The in vitro translation panel shows 5% of the input.
The amount of 6His-SMN that bound to GST or GST-SMN was assayed by
SDS-PAGE and Western blot. The input lane shows 10% of 6His-SMN.
About 5% of the 6His-SMN input is bound to GST-SMN (bottom). The
positions of the molecular weight markers are indicated on the left (in kD). 
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Gemin3 Interacts Directly with SMN and the 
Spliceosomal Sm Proteins In Vitro 
 
To further analyze the Gemin3 complex, we performed in
vitro protein-binding assay between Gemin3 and several
components of the SMN complex. For in vitro binding as-
says, Gemin3 was produced as a fusion protein with glu-
tathione S-transferase (GST), and SMN and Gemin2 were
produced and labeled with [
 
35
 
S]methionine by in vitro
transcription and translation in rabbit reticulocyte lysate.
Purified GST or GST–Gemin3 fusion immobilized on
gluthatione-Sepharose were incubated with labeled SMN
or Gemin2 proteins. After extensive washing, bound pro-
teins were eluted by boiling in SDS-containing sample
buffer and the eluted material was analyzed by SDS-
PAGE and detected by fluorography. Full-length SMN,
but not Gemin2, bound specifically to immobilized GST–
Gemin3 (Fig. 7 A), but not to GST alone (data not
shown). To investigate whether Gemin3 interacts with Sm
proteins, purified GST or GST–Gemin3 recombinant pro-
teins were used for binding assays with in vitro [
 
35
 
S]me-
thionine-labeled Sm proteins B, D1, D2, D3, E, F, and G
(Lehmeier et al., 1994; Herrmann et al., 1995; Raker et al.,
1996). The results, shown in Fig. 7 B, demonstrate that the
Sm proteins B and D3 bind to GST–Gemin3, whereas
there is no detectable binding to GST alone (data not
shown). D2 binds Gemin3 only weakly and we note that
the profiles of Sm protein binding to SMN and Gemin3
are not identical (see Liu et al., 1997). For example, SMN
binds to D1 whereas Gemin3 does not (Fig. 7; Liu et al.,
1997; Pellizzoni et al., 1999).
To address the possibility that some component of the
rabbit reticulocyte lysate mediates these interactions, wild-
type full-length SMN and SmB were produced as recombi-
nant 6His-tagged proteins and incubated with GST or
GST–Gemin3. After several rounds of washing, bound
proteins were solubilized by boiling in SDS sample buffer,
resolved by SDS-PAGE, immunoblotted, and probed with
a rabbit polyclonal antibody specific to the 6His-tag. As
shown in Fig. 7 C, SMN and SmB bind specifically to
Gemin3, but not to GST alone. We conclude that both
SMN and SmB interact directly with Gemin3.
To further characterize the interaction between Gemin3
and SMN, we first tested whether SMN carrying two
well-characterized mutations found in SMA patients, the
Y272C point mutant (SMNY272C) and the exon7 deletion
mutant (SMN
 
D
 
Ex7), the major product of the 
 
SMN2
 
 gene
(reviewed in Burghes, 1997; Talbot et al., 1997), are able to
interact with Gemin3. SMN wild-type and mutants were
produced and labeled with [
 
35
 
S]methionine by in vitro
transcription and translation in rabbit reticulocyte lysate.
Full-length wild-type SMN bound specifically to immobi-
lized GST–Gemin3 (Fig. 7 D). However, SMNY272C and
SMN
 
DEx7 are severely defective in their ability to bind
GST–Gemin3. No detectable binding was observed to
GST alone. Similar results were observed using purified
recombinant 6His-SMN wild-type and mutant proteins in-
stead of in vitro translated products (data not shown).
SMN oligomerization and Sm binding are not mutually
exclusive, and in fact, Sm binding is strongly enhanced by
SMN oligomerization (Pellizzoni et al., 1999; Fig. 7 E). To
determine whether SMN self-association enhances Gemin3
interaction, GST–SMN, or GST as a control, was preincu-
bated with a molar excess of recombinant 6His-tag SMN
to form SMN oligomers. After removing the unbound
6His-SMN by washing, in vitro translated [35S]methionine-
labeled Gemin3 and SmB were added and assayed for
binding (Fig. 7 E). As expected, SmB binding was strongly
enhanced by SMN oligomerization (Pellizzoni et al., 1999),
however, Gemin3 binding was not affected.
Gemin3 Interacts with SMN Via its Unique
COOH-Terminal Domain
The unwinding activity of DEAD box RNA helicases may
not be sequence specific. The target specificity of these
proteins is, at least in some cases, provided by their inter-
action with specific proteins of the RNP substrate. These
interactions appear to be mediated via the unique auxil-
iary domain that each RNA helicase contains (Hamm and
Lamond, 1998; Staley and Guthrie, 1998). Therefore, we
investigated the role of the unique COOH-terminal do-
main of Gemin3 (amino acids 430–825) in the interaction
and cellular localization of this novel DEAD box RNA
helicase. To do so, we constructed three deletion mutants
of Gemin3 and first tested their binding to GST–SMN.
Wild-type and mutant myc-Gemin3 constructs were tran-
scribed and translated in rabbit reticulocyte lysate in the
presence of [35S]methionine, and the resultant translated
products were assayed for binding to GST–SMN as de-
scribed above. As Fig. 8 B indicates, the wild-type myc-
Gemin3 protein and myc-DN368C277Gemin3 mutant pro-
teins interact specifically with GST–SMN, but not with
GST alone. The myc-DC328Gemin3 and myc-DN548
Gemin3 mutant proteins clearly do not interact with GST–
SMN. Thus, the COOH-terminal domain of Gemin3
(amino acids 456–547) mediates the interaction of SMN
with Gemin3.
We then monitored the expression and cellular localiza-
tion of the myc-tagged mutants in transfected HeLa cells.
Because gems represent a marker of a concentrated pool
of the SMN complex in the nucleus, it is likely that the in-
corporation of a myc-tagged Gemin3 protein into gems re-
sults from its interaction with SMN in vivo. Double-label
immunofluorescence microscopy, using anti-myc tag anti-
bodies to detect either the transfected wild-type myc-
Gemin3 or the myc-DGemin3 mutants, and the anti-SMN
mAb 2b1 antibody, showed accumulation of the wild-type
(data not shown) and myc-DN368C277Gemin3 mutants
into gems (Fig. 8 C). However, the myc-DC328Gemin3
and myc-DN548 (data not shown) Gemin3 mutant pro-
teins accumulate essentially in the cytoplasm without
any gems or nucleoplasm localization. This strongly sug-
gests that the COOH-terminal region of Gemin3 (amino
acids 456–547) is responsible for the localization of
Gemin3 into gems.
Discussion
The molecular characterization of the spinal muscular at-
rophy gene product, SMN, demonstrated that it is concen-
trated in novel nuclear structures called gems (Liu and
Dreyfuss, 1996; Liu et al., 1997). Coiled bodies and gems
represent nuclear structures that appear to be involved inCharroux et al. A DEAD Box Protein in the SMN Complex 1191
RNA metabolism, and in many of the cell lines studied,
these two bodies are often found in association (Lamond
and Carmo-Fonseca, 1993; Gall et al., 1995; Liu and Drey-
fuss, 1996; Liu et al., 1997; Matera and Frey, 1998; Pelliz-
zoni et al., 1998). SMN is also found in the cytoplasm,
where, together with its tightly associated partner, Gem-
in2, it functions in the assembly of snRNP particles (Fisher
et al., 1997; Pellizzoni et al., 1998). In the nucleus, SMN is
required for pre-mRNA splicing, and likely serves to as-
semble and maintain the splicing machinery in an active
form (Pellizzoni et al., 1998). To perform these functions,
SMN must either have an intrinsic activity or recruit other
proteins that can actively affect structural transitions to
the complex in certain RNP targets. Several factors that
have the capacity to serve in such functions, including as-
sembly and disassembly of components of the splicing ma-
chinery, have been described. Many of these factors are
DEAD/DEAH box RNA helicases that are essential for
splicing (reviewed in Staley and Guthrie, 1998). Prp43, for
instance, is required for the disassembly of the snRNP–
intron lariat complex (Arenas and Abelson, 1997), Prp22
is needed to release the mature mRNA from the spliceo-
some (Company et al., 1991), and Prp24 acts as a recycling
factor for U4 and U6 snRNP (Raghunathan and Guthrie,
1998).
Using a biochemical approach to characterize new com-
ponents of the SMN complex, we have identified a novel
DEAD box RNA helicase termed Gemin3. Gemin3 forms
a stable complex with SMN in vivo and in vitro, and it
colocalizes with SMN in nuclear gems. Several lines of evi-
dence suggest that Gemin3 and SMN function as a com-
plex in vivo. SMN and Gemin3 can be coimmunoprecipi-
tated and both are present in a large (z800 kD) complex
that also contains Gemin2. Anti-SMN, anti-Gemin2, or
anti-Gemin3 mAbs immunoprecipitate the spliceosomal
snRNP core Sm proteins, as well as several other unidenti-
fied proteins. Gemin3 interacts directly with SMN and
with several snRNP Sm core proteins, including B/B9, D2,
and D3. In addition, Gemin3 is uniformly distributed in
the cytoplasm, where snRNP assembly takes place, and it
can be specifically coimmunoprecipitated with the cyto-
plasmic pool of Sm proteins (data not shown). Together,
these findings suggest that Gemin3 may play an important
role in spliceosomal snRNP biogenesis.
DEAD box proteins have been found to be involved in
many aspects of RNA metabolism, including pre-mRNA
splicing, translation, snRNP–snRNP interactions, mRNA
degradation, and mRNA transport in eukaryotes and
prokaryotes (Company et al., 1991; Ohno and Shimura,
1996; Arenas and Abelson, 1997; Hamm and Lamond,
1998; Staley and Guthrie, 1998; De la Cruz et al., 1999).
One of the major questions about the function of each
DEAD/DEAH box RNA helicase is the identification of
the specific RNA target for it. Some of the enzymes of
this family can unwind generic RNA substrates in vitro
(Laggerbauer et al., 1998; Schwer and Gross, 1998; Wang
et al., 1998). For these enzymes, the specificity towards par-
ticular RNAs, therefore, appears to be determined by fac-
tors that interact with their unique auxiliary domains. For
example, the DEAH box RNA helicase Prp16 is recruited
to the spliceosome via its unique NH2-terminal domain
(Wang  and Guthrie, 1998). The specific substrate for
Gemin3 has not yet been identified and this remains a cen-
tral question of interest. In a series of preliminary experi-
ments, we have not been able to detect RNA helicase
or RNA-dependent ATPase activity for recombinant Gem-
in3, so far. It is possible that such activity will only mani-
fest itself when Gemin3 is associated with other proteins
as part of a complex or that it will be detectable once a
specific RNA or RNP target is found. The interaction of
Gemin3 with SMN is direct, and we found that amino ac-
Figure 8. Gemin3 interacts with SMN via its nonconserved
COOH-terminal domain. A, Schematic representation of the
myc-Gemin3 wild-type and deletion mutants used in the binding
assays. Black boxes represent the helicase motifs and the gray
box represents the auxiliary domain. B, In vitro translated
[35S]methionine-labeled wild-type and mutant myc-Gemin3 pro-
teins were incubated with purified GST-SMN or GST alone.
Bound myc-Gemin3 proteins were analyzed by SDS-PAGE and
fluorography. The in vitro translation panel shows 5% of the in-
put. C, Superimposed laser confocal images of double-label im-
munofluorescence experiments using an anti-myc tag rabbit af-
finity-purified polyclonal antibody against the 9E10 epitope
(green) and the anti-SMN mAb 2B1 (red) on HeLa cells
transiently transfected with myc-DC328Gemin3 or myc-
DN368C277Gemin3 mutants. Colocalization results in a yellow
signal. Gems are indicated by arrows; the dashed line demarcates
the nucleus.The Journal of Cell Biology, Volume 147, 1999 1192
ids 456–547 of Gemin3 mediate this interaction and, likely
as a consequence of this, the localization of Gemin3 to the
gems. Thus, we propose that Gemin3 provides the enzy-
matic activity of the SMN complex to affect structural
transitions in its RNA targets.
The SMN protein is capable of forming an oligomer of
.400 kD in vitro (Pellizzoni et al., 1999) and we show here
that SMN comigrates with an z800-kD complex that also
contains Gemin2 and Gemin3. It is likely that SMN oligo-
merization is critical for the nucleation of this large com-
plex. In addition to Gemin3 and Gemin2, several Sm pro-
teins interact with SMN, and we therefore propose that
SMN forms a docking platform to bring together, in the
appropriate spatial arrangement, the multiple proteins
that are involved in the de novo assembly and regenera-
tion of its RNP (e.g., snRNP) substrates. Interestingly, the
interaction of SMN with Gemin3 is severely reduced by
mutations found in SMA patients, such as the point mu-
tant SMNY272C or the exon 7 deletion. Thus, the forma-
tion of the SMN platform seems critical for SMN function
because SMA affects both the capacity of SMN to oligo-
merize, as well as to interact with several Sm proteins (Pel-
lizzoni et al., 1999) and Gemin3. As a likely consequence
of these defective interactions, the function of SMN in the
regeneration of the splicing machinery is abolished (Pelliz-
zoni et al., 1998, 1999).
Coiled bodies contain the highest local concentration of
p80 coilin and are enriched in components of three major
RNA processing pathways: pre-mRNA splicing; histone
mRNA 39 maturation; and pre-mRNA processing (re-
viewed in Lamond and Earnshaw, 1998). Gems contain
the highest local concentration of SMN, Gemin2, and
Gemin3 and are often found associated with coiled bodies
(Liu and Dreyfuss, 1996; Liu et al., 1997; and this work).
Although the definitive function of these two nuclear bod-
ies has not been completely elucidated, the characteriza-
tion of their protein and RNA contents represents an im-
portant step toward the understanding of their functions.
Further studies of Gemin3, a novel DEAD box containing
protein and component of gems, should shed light on the
functions of the SMN complex and gems.
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